Congressionally Directed Medical Research Programs (CDMRP) -- Lung Cancer Research Program -- Translational Research Partnership Award

Funding Agency:
Department of Defense

The FY19 LCRP Translational Research Partnership Award mechanism supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in lung cancer into clinical applications. This award supports the development of translational research collaborations between two independent, faculty-level (or equivalent) investigators to address a central problem or question in lung cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a research scientist and the other must be a clinician. In addition, one partner in the collaboration is strongly encouraged to be an active duty Service member or Federal employee from a Department of Defense (DoD) military treatment facility or laboratory, or a Department of Veterans Affairs (VA) medical center or research laboratory. It should be clear that both have had equal intellectual input into the design of the research project. Multi-institutional partnerships are encouraged but not required. At least one member of the partnership must have experience either in lung cancer research or lung cancer patient care. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this award mechanism.  

Observations that drive a research idea may be derived from a laboratory discovery, populationbased studies, or a clinician’s firsthand knowledge of patients and anecdotal data. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, members of the partnership should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between basic and clinical science. 

The success of the project must be supported by the unique skills and contributions of each partner. The proposed study must include clearly stated plans for interactions between the Principal Investigators (PIs) and institutions involved. The plans must include communication, coordination of research progress and results, and data transfer. Additionally, multi-institutional applications must provide an intellectual property plan to resolve potential intellectual and material property issues and to remove institutional barriers that might interfere with achieving high levels of cooperation to ensure the successful completion of this award.

Deadlines:
• Pre-Application Deadline:   May 15, 2019
• Invitation to Submit an Application: June 26, 2019
• Application Submission Deadline: August 21, 2019

Agency Website

Areas of Interest

To be considered for funding, applications for the FY19 LCRP Translational Research Partnership Award must address at least one of the nine Areas of Emphasis listed below:

• Identify innovative strategies for the screening and early detection of lung cancer.

• Understand the molecular mechanisms of initiation and progression to clinically significant lung cancer.

• Identify innovative strategies for prevention of the occurrence of lung cancer.

• Identify innovative strategies for the treatment of lung cancer.

• Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer 

• Develop or optimize predictive markers to assist with therapeutic decision-making.

• Understand mechanisms of resistance to treatment (primary and secondary).

• Understand contributors to lung cancer development other than tobacco.

• Identify innovative strategies for lung cancer care delivery (clinical management/ surveillance/symptom management).

Eligibility Requirements

• PIs must be at or above the level of Assistant Professor (or equivalent).

• The clinician must be an M.D., M.D./Ph.D., or equivalent with clinical duties and/or responsibilities. 

Amount

$900,000

Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY19 LCRP Translational Research Partnership Award will not exceed $900,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

Funding Type

Award
Grant

Eligibility

Faculty
Junior Faculty

Category

Medical
Medical - Translational

External Deadline

May 15, 2019